Swipe om te navigeren naar een ander artikel
Investigators for the Pediatric Quality of Life Inventory™ Gastrointestinal Symptoms Module Testing Study Consortium are listed in “Acknowledgements”.
The PedsQL™ is available at http://www.pedsql.org.
The primary objective was to investigate the mediating effects of patient-perceived medication adherence barriers in the relationship between gastrointestinal symptoms and generic health-related quality of life (HRQOL) in adolescents with inflammatory bowel disease (IBD). The secondary objective explored patient health communication and gastrointestinal worry as additional mediators with medication adherence barriers in a serial multiple mediator model.
The Pediatric Quality of Life Inventory™ Gastrointestinal Symptoms, Medicines, Communication, Gastrointestinal Worry, and Generic Core Scales were completed in a 9-site study by 172 adolescents with IBD. Gastrointestinal Symptoms Scales measuring stomach pain, constipation, or diarrhea and perceived medication adherence barriers were tested for bivariate and multivariate linear associations with HRQOL. Mediational analyses were conducted to test the hypothesized mediating effects of perceived medication adherence barriers as an intervening variable between gastrointestinal symptoms and HRQOL.
The predictive effects of gastrointestinal symptoms on HRQOL were mediated in part by perceived medication adherence barriers. Patient health communication was a significant additional mediator. In predictive analytics models utilizing multiple regression analyses, demographic variables, gastrointestinal symptoms (stomach pain, constipation, or diarrhea), and perceived medication adherence barriers significantly accounted for 45, 38, and 29 percent of the variance in HRQOL (all Ps < 0.001), respectively, demonstrating large effect sizes.
Perceived medication adherence barriers explain in part the effects of gastrointestinal symptoms on HRQOL in adolescents with IBD. Patient health communication to healthcare providers and significant others further explain the mechanism in the relationship between gastrointestinal symptoms, perceived medication adherence barriers, and HRQOL.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Prosberg, M. V., Vester-Andersen, M. K., Andersson, M., Jess, T., Andersen, J. T., Vind, I., et al. (2016). Long-term compliance with oral 5-aminosalicylic acid therapy and risk of disease recurrence in patients with ulcerative colitis: A population-based cohort study. Inflammatory Bowel Diseases, 22, 925–932. CrossRefPubMed
Muris, P., Roelofs, J., Rassin, E., Franken, I., & Mayer, B. (2005). Mediating effects of rumination and worry on the links between neuroticism, anxiety and depression. Personality and Individual Differences, 39, 1105–1111. CrossRef
de Jong-Meyer, R., Beck, B., & Riede, K. (2009). Relationships between rumination, worry, intolerance of uncertainty and metacognitive beliefs. Personality and Individual Differences, 46, 547–551. CrossRef
Varni, J. W., Shulman, R. J., Self, M. M., Saeed, S. A., Patel, A. S., Nurko, S., et al. (2017). Patient health communication mediating effects between gastrointestinal symptoms and gastrointestinal worry in pediatric inflammatory bowel disease. Inflammatory Bowel Diseases, 23, 704–711. CrossRefPubMed
Varni, J. W., Bendo, C. B., Denham, J., Shulman, R. J., Self, M. M., Neigut, D. A., et al. (2015). PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in pediatric patients with functional and organic gastrointestinal diseases in comparison to healthy controls. Quality of Life Research, 24, 363–378. CrossRefPubMed
Varni, J. W., Franciosi, J. P., Shulman, R. J., Saeed, S., Nurko, S., Neigut, D. A., et al. (2015). PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in pediatric patients with inflammatory bowel disease in comparison to healthy controls. Inflammatory Bowel Diseases, 21, 1115–1124. CrossRefPubMed
Varni, J. W., Bendo, C. B., Shulman, R. J., Self, M. M., Nurko, S., Franciosi, J. P., et al. (2015). Interpretability of the PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in pediatric patients with functional and organic gastrointestinal diseases. Journal of Pediatric Psychology, 40, 591–601. CrossRefPubMedPubMedCentral
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum.
Cohen, J., Cohen, P., West, S. G., & Aiken, L. S. (2003). Applied multiple regression/correlation analysis for the behavioral sciences (3rd ed.). Mahwah, NJ: Erlbaum.
Sobel, M. E. (1982). Asymptotic confidence intervals for indirect effects in structural equation models. Sociological Methodology, 13, 290–312. CrossRef
Hayes, A. F. (2013). Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. New York, NY: Guilford.
Gracie, D. J., Williams, C. J., Sood, R., Mumtaz, S., Bholah, M. H., Hamlin, P. J., et al. (2017). Negative effects on psychological health and quality of life of genuine irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease. Clinical Gastroenterology and Hepatology, 15, 376–384. CrossRefPubMed
Diederen, K., Hoekman, D. R., Hummel, T. Z., de Meij, T. G., Koot, B. G. P., Tabbers, M. M., et al. (2016). The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity. Alimentary Pharmacology & Therapeutics, 44, 181–188. CrossRef
Greenley, R. N., Gumidyala, A. P., Nguyen, E., Plevinsky, J. M., Poulopoulos, N., Thomason, M. M., et al. (2015). Can you teach a teen new tricks? Problem solving skills training improves oral medication adherence in pediatric patients with inflammatory bowel disease participating in a randomized trial. Inflammatory Bowel Diseases, 21, 2649–2657. CrossRefPubMed
Linn, A. J., van Dijk, L., Smit, E. G., Jansen, J., & van Weert, J. C. (2013). May you never forget what is worth remembering: The relation between recall of medical information and medication adherence in patients with inflammatory bowel disease. Journal of Crohn’s and Colitis, 7, e543–550. CrossRefPubMed
Szigethy, E., Bujoreanu, S. I., Youk, A. O., Weisz, J., Benhayon, D., Fairclough, D., et al. (2014). Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. Journal of the American Academy of Child and Adolescent Psychiatry, 53, 726–735. CrossRefPubMedPubMedCentral
Brooks, A. J., Rowse, G., Ryder, A., Peach, E. J., Corfe, B. M., & Lobo, A. J. (2016). Systematic review: Psychological morbidity in young people with inflammatory bowel disease—Risk factors and impacts. Alimentary Pharmacology & Therapeutics, 44, 3–15. CrossRef
Fresco, D. M., Frankel, A. N., Mennin, D. S., Turk, C. L., & Heimberg, R. G. (2002). Distinct and overlapping features of rumination and worry: The relationship of cognitive production to negative affective states. Cognitive Therapy and Research, 26, 179–188. CrossRef
- Perceived medication adherence barriers mediating effects between gastrointestinal symptoms and health-related quality of life in pediatric inflammatory bowel disease
James W. Varni
Robert J. Shulman
Mariella M. Self
Shehzad A. Saeed
George M. Zacur
Ashish S. Patel
Deborah A. Neigut
James P. Franciosi
Jolanda M. Denham
Chelsea Vaughan Dark
Cristiane B. Bendo
John F. Pohl
On Behalf of the Pediatric Quality of Life Inventory™ Gastrointestinal Symptoms Module Testing Study Consortium
- Springer International Publishing